Medication Management for Parkinson’s Disease
This activity consists of recorded presentations from the "29th Annual National Conference" held virtually Dec. 2–3, 2020.
Parkinson’s disease (PD) is a heterogeneous disease with rapidly and slowly progressive forms. Treatment involves both pharmacologic and nonpharmacologic approaches, such as exercise and physical-, occupational- and speech therapies. PD is associated with significant morbidity and utilization of health care resources, as well as premature death, particularly in those with dementia. While there are no currently available disease-modifying treatments for PD, timely diagnosis and treatment of PD symptoms can help preserve quality of life and reduce disability. This session will highlight the top PD symptoms and the use of medication as a key component of symptom management, review the typical progression of PD, the medications recommended during this progression and the adverse effects that may result from these medications. Recent advances and the potential future applications in PD medication management will also be discussed.
This activity is provided by OptumHealth Education.
There was no commercial support for this activity.
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
This activity is designed to meet the educational needs of case managers, nurses, pharmacists, pharmacy technicians, physicians, psychologists, social workers and other health care professionals who are interested in parkinson’s disease.
At the end of this educational activity, participants should be able to:
- Describe the typical progression of PD and medications recommended during this progression.
- Discuss medications with the greatest impact for top motor and nonmotor symptoms.
- Explain the adverse effects that may result from medications and how to best address these issues with PD patients and their families.
- Identify recent advances in medication management for PD and potential future applications.
- Explain dopamine-agonist-withdrawal syndrome (DAWS) and the complications that can arise from sudden withdrawal of PD medications.
Medication Management for Parkinson’s Disease
Sarah Chart, RN
Eden Prairie, MN
Rebecca Gleason, RN, CCM
Eden Prairie, MN
Alan N. Langnas, DO, FACS
Professor of Surgery
Director, Center of Transplantation
Chief, Section of Transplantation,
Department of Surgery
University of Nebraska Medical Center;
Director of Liver Transplantation
C. Fred LeMaistre, MD
Senior Vice President, Market Operations
Tina Rydland, PharmD
Crystal Clear Rx
Crystal Wong, MD
Propoint Medical Writing
Disclosures of relevant financial relationships
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education (OHE) requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or his/her spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services relate to the activity content. OHE ensures that the content is independent of commercial bias.
Dr. Pahwa has indicated that he has the following to disclose: Abbott, AbbVie (advisory board, consultant, grant/research support); ACADIA, Acorda, Adamas, Amneal, CalaHealth, DisperSol technologies, Global Kinetics, Impel, Neuropharma, Kyowa, Lundbeck, Mitsubishi, Neurocrine, Orbis Bioscience, PhotoPharmics, Prilenia, Sunovion, Teva Neuroscience and US WorldMeds (advisory board, consultant); Addex, Biogen, Biohaven, Boston Scientific, EIP, Global Kinetics, Impax, Intec, Lilly, Neuroderm, Neuraly, Parkinson’s Foundation, Pharma 2B, Prelinia, Roche, Sage, SIS, Sun Pharma,
Sunovion, Theranexus, Theravance, US WorldMeds and Voyager (grant/research support)
Dr. Wong has indicated that she has received grant/research support from MyoKardia.
The remaining activity faculty and planners have no financial relationships to disclose.
Method for calculating CE credit
CE credit was calculated by the complexity of content.
In support of improving patient care, OptumHealth Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation Statements
The participant will be awarded up to 0.50 contact hour(s) of credit for attendance and completion of supplemental materials.
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
This activity is approved for 0.50 contact hour(s) ([0.05] CEU) in states that recognize ACPE.
Attending the full program will earn 0.50 contact hour(s).
Unique Activity Number(s): JA0007123-0000-21-130-H01-P/T
OptumHealth Education designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
The Commission for Case Manager Certification has approved this program for a maximum of 0.50 clock hour(s) for Certified Case Managers (CCM).
Psychologists and social workers
Participants must have attended the entire Web-based activity and completed an evaluation to receive a certificate. Partial credit is not available.
OptumHealth Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. OptumHealth Education maintains responsibility for this program. 0.50 CE hour.
As a Jointly Accredited Organization, OptumHealth Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. OptumHealth Education maintains responsibility for this course. Social workers completing this course receive 0.50 enduring continuing education credit.
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
- 0.50 ACPE - Pharmacist
- 0.50 ACPE - Pharmacy Technician
- 0.50 AMA
- 0.50 ANCC
- 0.50 APA
- 0.50 Attendance
- 0.50 CCMC - General
Prior to beginning this activity, please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
You must be logged into your account to participate in this activity. Get started by clicking “Continue” and taking the “Pre-Activity Assessment”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account”, “My Activities.”